Arcadia Biosciences, Inc.

RKDA Nasdaq CIK: 0001469443

Company Information

Industry Crude Petroleum & Natural Gas
SIC Code 1311
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 5956 SHERRY LANE, DALLAS, TX,
Mailing Address 5956 SHERRY LANE, DALLAS, TX,
Phone 214-974-8921
Fiscal Year End 1231
EIN 810571538

Financial Overview

FY2024

$19.70M
Total Assets
$6.52M
Cash & Equivalents

Recent SEC Filings

Form Type Date Filed Document
8-K Current report of material events February 6, 2026 View on SEC
S-3 Shelf registration for future offerings January 28, 2026 View on SEC
8-K Current report of material events January 14, 2026 View on SEC
8-K Current report of material events December 29, 2025 View on SEC
8-K Current report of material events December 23, 2025 View on SEC
DEF 14A Definitive proxy statement November 19, 2025 View on SEC
8-K Current report of material events November 7, 2025 View on SEC
10-Q Quarterly financial report November 7, 2025 View on SEC
8-K Current report of material events October 24, 2025 View on SEC
8-K Current report of material events August 29, 2025 View on SEC

Material Events

8-K Strategy Change December 29, 2025
High Impact
  • Arcadia Biosciences' planned merger with Roosevelt Resources, LP has been terminated.
  • Roosevelt Resources terminated the agreement because the merger did not close by the extended deadline of August 15, 2025.
View Analysis

Related Companies

Companies in the same industry (SIC: 1311)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.